Pharmaceutical Executive June 12, 2024
Hypermedica and Ro announced platforms to help patients find access to affordable weight loss medications.
Virtual care and telehealth company Hypermedica announced that is has formed partnerships with various pharmacies from around the U.S. to address shortages and rising costs of GLP-1 medications.1 These medications are popular weight loss treatments and have seen demand skyrocket in the past two years. According to Hypermedica, its goal is to ensure that patients have access to these medications without having to utilize unreputable sources.
Hypermedica plans to use its digital platform to connect patients with services like real-time consultations, monitoring, and treatments and allow more patients to find sources of GLP-1 medications without being limited to their geographical location. The company is offering...